PUX Stock Overview
Engages in the extraction and processing of cannabis and hemp to produce oils and various derivative products in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Pure Extracts Technologies Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.0049 |
| 52 Week High | CA$0.025 |
| 52 Week Low | CA$0.001 |
| Beta | 2.96 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -83.22% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -98.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| PUX | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 1.1% |
| 1Y | -83.2% | -19.0% | 7.2% |
Return vs Industry: PUX underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: PUX underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| PUX volatility | |
|---|---|
| PUX Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PUX has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PUX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Ben Nikolaevsky | pureextractscorp.com |
Pure Extracts Technologies Corp. engages in the extraction and processing of cannabis, hemp, and functional mushrooms to produce oils and various derivative products in Canada. The company offers THC and CBD based extracted oils. It also engages in the development and commercialization of functional mushroom wellness products and psychedelic medical products.
Pure Extracts Technologies Corp. Fundamentals Summary
| PUX fundamental statistics | |
|---|---|
| Market cap | €793.85k |
| Earnings (TTM) | -€3.21m |
| Revenue (TTM) | €1.31m |
0.6x
P/S Ratio-0.2x
P/E RatioIs PUX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PUX income statement (TTM) | |
|---|---|
| Revenue | CA$1.93m |
| Cost of Revenue | CA$2.41m |
| Gross Profit | -CA$483.74k |
| Other Expenses | CA$4.24m |
| Earnings | -CA$4.72m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.04 |
| Gross Margin | -25.07% |
| Net Profit Margin | -244.84% |
| Debt/Equity Ratio | 156.3% |
How did PUX perform over the long term?
See historical performance and comparison